Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A renewed check-up marketed as an possibility to a mammogram for teat cancer detection is not an moving screening TOOL, US health officials say. With the nipple aspirate test, a chest quiz collects fluid from a woman's nipple. The solution is then examined for unconventional and potentially cancerous cells vigrxplus.top. The investigation is advertised as easier, more comfortable and less painful than mammograms.

However, there is no tough to support claims that the test can identify breast cancer, said Dr David Lerner, a medical cop at the US Food and Drug Administration and a mamma imaging specialist. "FDA's involved with is that the nipple aspirate examine is being touted as a standalone tool to screen for and name breast cancer as an alternative to mammography," Lerner said in an intercession news release.

So "Our fearfulness is that women will forgo a mammogram and have this assay instead". Skipping a mammogram could put a woman's strength and life at risk if breast cancer goes undetected, Lerner warned. He said there is no orderly suggestion that the nipple aspirate test, when cast-off on its own, is an effective screening tool for heart cancer or any other medical condition.

Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A untrained probe marketed as an choice to a mammogram for knocker cancer detection is not an capable screening TOOL, US health officials say. With the nipple aspirate test, a heart of hearts cross-examine collects fluid from a woman's nipple. The protean is then examined for weird and potentially cancerous cells dailymotion. The examine is advertised as easier, more comfortable and less painful than mammograms.

However, there is no documentation to support claims that the test can feel breast cancer, said Dr David Lerner, a medical dignitary at the US Food and Drug Administration and a bosom imaging specialist. "FDA's worry is that the nipple aspirate assay is being touted as a standalone tool to screen for and determine breast cancer as an alternative to mammography," Lerner said in an force news release.

So "Our apprehension is that women will forgo a mammogram and have this check instead". Skipping a mammogram could put a woman's form and life at risk if breast cancer goes undetected, Lerner warned. He said there is no precise demonstration that the nipple aspirate test, when worn on its own, is an effective screening tool for heart cancer or any other medical condition.